CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- 4 Grant or award Director acquired 7,375 shares (grant or award)
- 4 Grant or award Director acquired 6,217 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Interim CFO bought 5,000 shares at $3.22 ($16,100)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion SVP, Chief Scientific Officer acquired 40,000 shares (option exercise)
- 4 Grant or award Chief Medical Officer acquired 43,750 shares (grant or award)
- 4 Grant or award President, Chief Exec Officer acquired 85,000 shares (grant or award)
- 4 Grant or award SVP, Chief Scientific Officer acquired 43,750 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Gift Director gave 1,470 shares (gift)
- 4 Open-market sale SVP, Principal Accntng Officer sold 3,602 shares at $8.00 ($28,816)
- 4 Gift Director gave 4,500 shares (gift)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, Principal Accntng Officer sold 1,801 shares at $9.10 ($16,389)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP, Chief Scientific Officer sold 10,000 shares at $10.20 ($102,000)
- 4 Open-market sale SVP, Principal Accntng Officer sold 1,801 shares at $10.00 ($18,010)
Page 6 of 28 · 550 filings